Not applicableStudy completedNCT00003863What this trial is testingDiagnostic Study of Patients With Aggressive Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 391
Early research (Phase 1)Study completedNCT00243087What this trial is testingInvestigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)Who this might be right forLymphoma Boehringer Ingelheim 41
Not applicableStudy completedNCT00398372What this trial is testingClinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody TreatmentWho this might be right forLymphoma, Non-HodgkinLymphomas: Non-HodgkinLymphomas: Non-Hodgkin Cutaneous Lymphoma+6 more Stanford University 500
Testing effectiveness (Phase 2)Study completedNCT04716075What this trial is testingAcalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)Who this might be right forChronic Lymphocytic LeukemiaChronic Graft-versus-host-diseaseMantle Cell Lymphoma+2 more Polish Lymphoma Research Group 29
Early research (Phase 1)Ended earlyNCT03151057What this trial is testingIdelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived MalignanciesWho this might be right forB Cells-TumorsB Cell Chronic Lymphocytic LeukemiaFollicular Lymphoma+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Study completedNCT00047164What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine TherapyWho this might be right forLymphoma National Institutes of Health Clinical Center (CC) 89
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00703664What this trial is testingBortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell LymphomaWho this might be right forRecurrent Mantle Cell LymphomaRecurrent Non-Hodgkin Lymphoma National Cancer Institute (NCI) 65
Not applicableWithdrawnNCT04231734What this trial is testingKetogenic Diet in Patients With Untreated Low Tumor Burden Mantle Cell LymphomaWho this might be right forMantle Cell LymphomaKetogenic Dieting Weill Medical College of Cornell University
Early research (Phase 1)Looking for participantsNCT04830137What this trial is testingNX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Waldenstrom Macroglobulinemia (WM)+5 more Nurix Therapeutics, Inc. 248
Post-approval studies (Phase 4)Study completedNCT04930536What this trial is testingAcalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell LymphomaWho this might be right forChronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma AstraZeneca 103
Not applicableLooking for participantsNCT06339255What this trial is testingItalian Observational Study on CAR-T Therapy for LymphomaWho this might be right forDiffuse Low Grade B-Cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)Mantle Cell Lymphoma+1 more Paolo Corradini 5,300
Not applicableWithdrawnNCT00093678What this trial is testingCelecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWho this might be right forCachexiaLymphomaMelanoma (Skin)+4 more Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07799220What this trial is testingZanubrutinib, Obinutuzumab, and Sonrotoclax in People With Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00025662What this trial is testingSelective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDSWho this might be right forGraft vs Host DiseaseMyelodysplastic SyndromesLeukemia+7 more National Heart, Lung, and Blood Institute (NHLBI) 23
Testing effectiveness (Phase 2)Study completedNCT00003874What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01665768What this trial is testingMaintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in LymphomaWho this might be right forCD20+, B-cell LymphomasMantle Cell LymphomaNon-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL)+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 56
Testing effectiveness (Phase 2)Study completedNCT02736617What this trial is testingObinutuzumab in Combination With Ibrutinib in Treating Patients With Relapsed Mantle Cell LymphomaWho this might be right forRecurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma OHSU Knight Cancer Institute 10
Testing effectiveness (Phase 2)Ended earlyNCT00871546What this trial is testingSCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715)Who this might be right forLymphoma, Mantle-CellLeukemia, Lymphocytic, Chronic, B-Cell Merck Sharp & Dohme LLC 8